Suppression of BMP signaling by PHD2 deficiency in Pulmonary Arterial hypertension

Bin Liu, Dan Yi, Jiakai Pan, Jingbo Dai, Maggie M. Zhu, You Yang Zhao, S. Paul Oh, Michael B. Fallon, Zhiyu Dai*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

BMP signaling deficiency is evident in the lungs of patients with pulmonary arterial hypertension. We demonstrated that PHD2 deficiency suppresses BMP signaling in the lung endothelial cells, suggesting the novel mechanisms of dysregulated BMP signaling in the development of pulmonary arterial hypertension.

Original languageEnglish (US)
Article numbere12056
JournalPulmonary Circulation
Volume12
Issue number1
DOIs
StatePublished - Jan 2022

Funding

This study was supported in part by NIH grants R01HL140409, R01HL133951, R01HL148810 to You‐Yang Zhao, and NIH R00HL13827, AHA Career Development Award 20CDA35310084, ATS Foundation Pulmonary Hypertension Association Research Fellowship, Arizona Biomedical Research Centre funding (ADHS18‐198871), and the University of Arizona departmental Startup funding to Zhiyu Dai. The authors thank the Pulmonary Hypertension Breakthrough Initiative for providing the lung endothelial cells from IPAH patients and failed donors. Funding for the Pulmonary Hypertension Breakthrough Initiative is provided under an NHLBI R24 grant (R24HL123767).

Keywords

  • BMPR2
  • angiogenesis
  • hypoxia
  • pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Suppression of BMP signaling by PHD2 deficiency in Pulmonary Arterial hypertension'. Together they form a unique fingerprint.

Cite this